Artificial intelligence is rapidly advancing the capabilities and possibilities of whole genome sequencing. Through the use of this advanced technology, the pharmaceutical industry can deliver precise dosing on a scale and at a level of accuracy never before seen. AI can provide personalized predictions to determine likely physical and psychological effects of drug interaction in an individual body.
While big data is increasing our access to questions, it is also creating new discoveries and new questions that have yet to be answered. One thing is for sure, AI, big data, and whole genome sequencing will impact the cost of drug development and delivery. This webinar will explore these topics in depth.